Old Web
English
Sign In
Acemap
>
authorDetail
>
Salome Juethner
Salome Juethner
Takeda Pharmaceutical Company
Medicine
Hereditary angioedema
Lanadelumab
Receptor–ligand kinetics
Immunology
4
Papers
8
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Response to lanadelumab is not affected by race and ethnicity: findings from phase 3 studies
2021
The Journal of Allergy and Clinical Immunology
Timothy J. Craig
Rafael H. Zaragoza-Urdaz
John Anderson
Huamin Li
Kim Paes
Clinical Scientist
Hong Ren
Salome Juethner
Show All
Source
Cite
Save
Citations (0)
Transition of Care from Pediatric to Adult Care in Eosinophilic Esophagitis: Insights from a Patient Perspective Survey.
2021
Journal of Pediatric Gastroenterology and Nutrition
Jane Robinson
Glenn T. Furuta
Nandini Hadker
Irana Kolev
James H. Williams
Salome Juethner
Gary W. Falk
Show All
Source
Cite
Save
Citations (0)
Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks.
2020
Allergy
Marc A. Riedl
Marcus Maurer
Jonathan A. Bernstein
Aleena Banerji
Hilary Longhurst
H. Henry Li
Peng Lu
James Hao
Salome Juethner
William R. Lumry
Show All
Source
Cite
Save
Citations (8)
Hereditary angioedema (HAE) prophylaxis with plasma kallikrein inhibitors: Role of target binding kinetics, pharmacokinetics and treatment adherence
2020
The Journal of Allergy and Clinical Immunology
Rangaraj Narayanan
Haobin Luo
Zhiwei Zhang
Paul Jasper
Peng Lu
Salome Juethner
Dan Sexton
Show All
Source
Cite
Save
Citations (0)
1